Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer
Conditions: Oropharyngeal Squamous Cell Carcinoma; Human Papillomavirus Infection Interventions: Genetic: Pre-Radiation Dental Evaluation/Sample Collection; Other: Pre-Study Visit; Genetic: Oral Medicine Consultation Visit/Sample Collection Sponsors: Wake Forest University Health Sciences; InnoTech Precision Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Communicating Human Papillomavirus Vaccine With Japanese Parents and Caregivers With Daughters Aged 12-18
Conditions: Healthy Interventions: Behavioral: Group 1 (I x S x S x F); Behavioral: Group 2 (O x S x S x F); Behavioral: Group 3 (I x E x S x F); Behavioral: Group 4 (O x E x S x F); Behavioral: Group 5 (I x S x S x M); Behavioral: Group 6 (O x S x S x M); Behavioral: Group 7 (I x E x S x M); Behavioral: Group 8 (O x E x S x M); Behavioral: Group 9 (I x S x D x F); Behavioral: Group 10 (O x S x D x F); Behavioral: Group 11 (I x E x D x F); Behavioral: Group 12 (O x E x D x F); Behavioral: Group 13 (I x S x D x M); Behavioral: Group 14 (O x S x D x M); Behavioral: Group 15 (I x E x D x M); Behavioral: Group 16 (O x E x D x ...
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
Immunogenicity and Safety of One Dose of HPV Vaccine
Conditions: Human Papillomavirus Vaccines Interventions: Biological: HPV vaccine Sponsors: Xiamen Innovax Biotech Co., Ltd Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
Vaginal Self-sampling for Detecting High-risk Human Papillomavirus Cervical Infection in Patients With Immune-mediated Inflammatory Diseases
Conditions: HPV Infection; Systemic Disease Interventions: Procedure: Vaginal self sampling detecting HPV Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials
Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC ®) in Women Living With HIV Aged 15-25 Years
Conditions: Human Papillomavirus Infection Interventions: Biological: Cervavac as three dose regimen; Biological: Cervavac as two dose regimen; Biological: Gardasil as three dose regimen Sponsors: Serum Institute of India Pvt. Ltd.; Bill and Melinda Gates Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3
Conditions: Human Papillomavirus Associated Intraepithelial Neoplasia; Cervical Intraepithelial Neoplasia Grade 2/3; Human Papillomavirus Type 16 Infection; Human Papillomavirus Type 18 Infection Interventions: Biological: RG002 injection Sponsors: RinuaGene Biotechnology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Car-cinoma in Women Undergoing Conization
Conditions: Cervical Intraepithelial Neoplasia Grade 2/3; Recurrence Interventions: Biological: vaccination against human papillomavirus infection (HPV vaccination) Sponsors: Charles University, Czech Republic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing Conization
Conditions: Cervical Intraepithelial Neoplasia Grade 2/3; Recurrence Interventions: Biological: vaccination against human papillomavirus infection (HPV vaccination) Sponsors: Charles University, Czech Republic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care
Conditions: Human Papillomavirus Infection Interventions: Other: Educational Intervention Sponsors: Roswell Park Cancer Institute; National Cancer Institute (NCI); National Institute on Minority Health and Health Disparities (NIMHD) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Evaluation of First-void Urine as an Alternative to Cervical Sampling for Human Papillomavirus (HPV) Testing in Cervical Cancer Screening (Single-center Study).
Conditions: Uterine Cervical Cancer Interventions: Other: Urine sample, 1st stream; Other: Cervico-vaginal swab Sponsors: Centre Hospitalier Universitaire de Saint Etienne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma
Conditions: Oropharynx Cancer, Stage I Interventions: Biological: Atezolizumab; Procedure: Transoral Surgery with cervical lymphadenctomy (neck dissection); Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging Sponsors: Emory University; National Cancer Institute (NCI); Genentech, Inc. Suspended (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Probiotc Lactobacillus Crispatus-M247 (Crispact ®) Supplementation in the Sterilization of High-risk Human Papilloma (HPV-HR) Viruses
Conditions: Human Papillomavirus Infection Interventions: Dietary Supplement: Crispact ®; Dietary Supplement: Placebo Sponsors: Liaquat University of Medical& Health Sciences; Universit à degli Studi dell ' Insubria Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls
Conditions: Cervical Intraepithelial Neoplasia; Cervical Cancer; Persistent Infection Interventions: Biological: Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli); Other: No intervention; Biological: Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) Sponsors: Xiamen University; Xiamen Innovax Biotech Co., Ltd; Center for Disease Control and Prevention, Sheyang County, Yancheng City, Jiangsu Province, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer
Conditions: Squamous Cell Carcinoma of the Head and Neck; Oropharynx; Human Papillomavirus Viruses; Drug Therapy; Cancer Vaccine Interventions: Drug: Docetaxel; Drug: Cisplatin; Drug: PRGN-2009 Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Comparison of Self-collection Using Dry Compared to Wet Swabs for HPV Detection
Conditions: Human Papillomavirus Infection Interventions: Device: • COPAN Self-collection FLOQSwabs® (COPAN, Italy) Sponsors: Foundation for Innovative New Diagnostics, Switzerland; Kenya Medical Research Institute; Frere Hospital, East London, South Africa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
